From the public health perspective the issue is one of confidence. We can only stop the pandemic if enough people have faith in the vaccine - that has been widely reported.
Not taking shortcuts is an argument here. Emergency procedures do take shortcuts.
That's not an easy decision.
I have much sympathy for @BrunoBrussels 's choice (I want a vaccine for my dad NOW - that's his Dad, mine has died) - and it would have been mine, too, probably. But I see the arguments for the other side.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
The weird debate about drug approval and Brexit that is currently going is interesting for several regulatory aspects (thread)
1) The headlines "first in the race" show the enormous pressure on a regulatory regime set up to be independent and evaluate thoroughly.
If this were a race in which being first is the most important thing, Russia would have won. A reminder: this is not the point of approval.
Fortunately I have faith in the MHRA. I believe they work well. The best way to destroy them, though, is to start regarding drug approval as a race in which the first one wins.
Some home truths about the time left to negotiate an EU-UK FTA if we want one in place by January. Or in short: Why we're reaching the end of the road. (Thread)
This is wrong. It is utterly common for an FTA to add “unrelated conditions” about domestic regulation. Even the WTO Agreements contain an agreement on intellectual property. CPTPP has stuff on IP, environment, labour, regulatory coherence. Etc. Etc.
One of the curious issues in this regard is the term “unrelated”. When the WTO’s IP Agreement “TRIPS” was negotiated, this was a big issue. “TR” stands for “trade-related”.
Developing countries tried to take a stand - they said “we first want to know what trade-related IP rights are - and which ones aren’t”. But they lost that debate. TRIPS is a general IP agreement. “Trade-related” came to mean something more nebulous.
To those worried that 600+ pages signal concern, a short illustration of the length of trade agreements. You remember CPTPP? The one we have decided to like? OK. Let’s go there. You might have thought that it’s short and sweet, as NZ lists this 9-pager as CPTPP, right? (Thread)
Well. Look at it. It incorporates TPP. That’s Art. 1. So let’s look at what that means. Here’s the NZ website. A loooong page. Full with links. That are part of the text. How long you ask? /3 mfat.govt.nz/en/trade/free-…
The Trade Committee's report on UK-Japan - the Committee considers a debate as critical. Allow me to reinforce that argument with some detail. (Thread)
The Committee rightly states that UK-Japan and EU-Japan are largely similar, but differ in some respects. Let me identify one of those aspects: Intellectual Property law. /2
This is what the Committee writes in that regard: the UK-Japan FTA goes beyond the EU-Japan one. But what does this mean? /3